SCHERMA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 93.826
NA - Nord America 4.086
AS - Asia 503
SA - Sud America 8
AF - Africa 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 98.433
Nazione #
IT - Italia 92.896
US - Stati Uniti d'America 4.065
CN - Cina 355
SE - Svezia 301
UA - Ucraina 278
FI - Finlandia 94
GB - Regno Unito 87
DE - Germania 86
VN - Vietnam 45
TR - Turchia 35
SG - Singapore 32
FR - Francia 23
CA - Canada 18
BE - Belgio 11
IR - Iran 11
NL - Olanda 11
IN - India 10
IE - Irlanda 8
BR - Brasile 7
KR - Corea 6
AT - Austria 5
CZ - Repubblica Ceca 4
RU - Federazione Russa 4
AU - Australia 3
HR - Croazia 3
HU - Ungheria 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
EU - Europa 2
HK - Hong Kong 2
MX - Messico 2
NG - Nigeria 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
ZA - Sudafrica 1
Totale 98.433
Città #
Cagliari 92.546
Fairfield 589
Woodbridge 416
Chandler 360
Ashburn 326
Houston 293
Ann Arbor 279
Nyköping 255
Seattle 240
Wilmington 208
Cambridge 186
Jacksonville 150
Dearborn 127
Boardman 86
New York 67
Shanghai 62
Beijing 60
Boston 57
Nanjing 57
Helsinki 50
Dong Ket 45
San Diego 34
Shenyang 32
Redwood City 29
Washington 27
Kocaeli 24
Milan 24
Mountain View 19
Rome 18
Verona 15
Hebei 13
Jiaxing 13
Sassari 13
Guangzhou 12
Toronto 12
Brussels 11
Changsha 11
Arlington 10
London 10
Tertenìa 10
Hefei 9
Ningbo 9
Norwalk 9
Orange 9
Dublin 8
Nanchang 8
Phoenix 8
San Sperate 8
Tianjin 8
Atlanta 7
Auburn Hills 7
Shenzhen 7
Istanbul 6
Monmouth Junction 6
Amsterdam 5
Kunming 5
Quartu Sant'Elena 5
Redmond 5
Arezzo 4
Fremont 4
Hangzhou 4
Iglesias 4
Millbury 4
Modena 4
Naples 4
Pisa 4
Zhengzhou 4
Augusta 3
Baltimore 3
Budapest 3
Falls Church 3
Jinan 3
Maringá 3
Montague 3
Perugia 3
Pune 3
Quartu Sant'elena 3
San Mateo 3
Selargius 3
Seoul 3
Sèlegas 3
Teramo 3
Torino 3
Vienna 3
Wuhan 3
Zagreb 3
Aci Sant'antonio 2
Assemini 2
Bergamo 2
Berlin 2
Bristol 2
Catania 2
Central 2
Chengdu 2
Cosenza 2
Council Bluffs 2
Cremona 2
Dammam 2
Dar es Salaam 2
Dolceacqua 2
Totale 97.046
Nome #
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.582
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.080
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.030
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 2.874
Emotional profile of female rats showing binge eating behavior 2.791
Limited access to a high fat diet alters endocannabinoid tone in female rats 2.764
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.652
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.603
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.591
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.551
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 2.533
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.516
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.358
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.235
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.232
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.116
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.098
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.066
Brain activity of anandamide: a rewarding bliss? 1.984
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 1.978
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 1.975
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 1.947
New perspectives on the use of cannabis in the treatment of psychiatric disorders 1.922
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 1.889
Animal Models of Eating Disorders 1.886
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.722
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.707
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.615
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.567
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.523
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.509
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.349
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.346
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.258
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.214
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.184
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.168
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.127
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.119
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 818
Cannabinoids and their therapeutic applications in mental disorders 816
Endocannabinoid system and opioid addiction: behavioural aspects 810
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 802
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 799
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 755
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 746
Cannabinoid-opioid interaction in relapse to drug-seeking 740
null 738
null 711
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 693
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 679
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 659
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 646
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 642
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 618
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 608
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 597
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 570
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 548
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 521
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 479
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 443
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 427
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 411
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 366
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 323
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 259
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 244
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 235
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 230
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 229
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 152
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 122
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 119
Cannabinoids and reward: Interactions with the opioid system 117
An overall view of the most common experimental models for multiple sclerosis 112
Modeling Anorexia Nervosa 99
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 96
Cannabinoid-nicotine interactions 48
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 4
null 3
Totale 98.695
Categoria #
all - tutte 117.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.064 0 0 0 0 0 0 0 0 0 255 428 381
2019/202021.664 977 535 136 345 7.689 6.458 3.024 624 402 407 403 664
2020/202129.989 887 1.305 1.073 9.510 5.920 3.179 2.209 1.580 693 1.323 1.330 980
2021/20227.549 998 507 284 662 847 523 355 327 678 873 880 615
2022/202311.593 792 1.339 1.631 923 891 1.188 695 956 816 835 1.035 492
2023/20248.874 526 385 470 700 1.179 1.944 1.854 736 631 449 0 0
Totale 98.695